4-(4-Bromo-2-methylphenyl)-4-oxobutyric acid, 97.0%, 5g

7-METHYL-1,2,3,4-TETRAHYDROQUINOLINE, 95%, 500mg

4-Amino-6-chloro-1,3-benzenedisulfonamide, 95.0%, 10g

2,5-Dimethylpyrazine>98.0%(GC)(T)100mL

(S)-tert-Butyl 2-(bromomethyl)morpholine-4-carboxylate, 95.0%, 1g

Dicyclopropylmethanamine hydrochloride, 95.0%, 25g

3-Bromo-2-(bromomethyl)prop-1-ene, 95.0%, 1g

2-(1,1-DIFLUOROETHYL)ISONICOTINIC ACID, 95%, 250mg

GC capillary column ROTI®Cap-FFAP, 60 m, 0.25 mm, 0.25 µm, 1 Piece(s)

5-tert-butyl 3-ethyl 7-methyl-2H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-3,5-dicarboxylate, 98%, 500mg

3-Bromo-1-chloro-4-fluorobenzene, 98.0%, 500g

METHYL 3-BROMOINDAZOLE-6-CARBOXYLATE, 95%, 100g

Methanesulfonato(2-dicyclohexylphosphino-3,6-dimethoxy-2',4',6'-tri-i-propyl-1,1'-biphenyl)(2'-amino-1,1'-biphenyl-2-yl)palladium(II), 98%, 250mg